These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 10848874

  • 1. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC, Glasier AF, Illingworth PJ, Baird DT.
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ, Rees LH, Besser GM.
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
    Kato K, Watanabe R, Ito E, Sakamoto T, Morishima M, Hoshino K, Tanaka M, Tadokoro N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.
    Berinder K, Stackenäs I, Akre O, Hirschberg AL, Hulting AL.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):450-5. PubMed ID: 16181238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of bromocriptine administration during the follicular phase of the oestrous cycle on prolactin and gonadotrophin secretion and follicular dynamics in merino monovular ewes.
    Picazo RA, González De Bulnes A, Gómez Brunet A, del Campo A, Granados B, Tresguerres J, López Sebastián A.
    J Reprod Fertil; 2000 Sep; 120(1):177-86. PubMed ID: 11006160
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B, Nesher Y, Barziliai S.
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.